Clinical Study

Evaluation of the Effect of Concurrent Chronic Total Occlusion and Successful Staged Revascularization on Long-Term Mortality in Patients with ST-Elevation Myocardial Infarction

Table 5

Independent predictors of early (0–30 days) and late (30 days–3 years) mortality.

Variable HR (95% CI) value

Predictors of overall 3-year mortality
 Shock on admission4.6 (3.5–6.7)<0.01
 MVD with CTO2.3 (1.5–2.8)<0.01
 CrCL < 60 mL/min1.6 (1.1–2.2)<0.05
 History of prior MI1.6 (1.1–2.3)<0.05
 History of congestive heart failure2.8 (1.7–4.7)<0.01
 LAD-related MI2.1 (1.6–2.8)<0.01
 TIMI flow 3 post-PCI0.6 (0.4–0.8)<0.01
Predictors of 30-day–3-year mortality
 Shock on admission2.1 (1.2–2.9)<0.05
 MVD with CTO1.9 (1.4–3.6)<0.01
 MVD without CTO1.1 (0.8–1.6)0.50
 History of congestive heart failure2.6 (1.4–4.5)<0.01
 LAD-related MI1.9 (1.5–2.4)<0.01
Predictors of 30-day mortality
 Shock on admission7.8 (5.9–9.8)<0.01
 MVD with CTO3.4 (2.4–4.5)<0.01
 MVD without CTO1.7 (1.3–2.3)<0.05
 LAD-related MI1.5 (1.2–1.8)<0.05
 TIMI flow 3 after PCI0.5 (0.3–0.8)<0.01

CI: confidence interval; HR: hazard ratio; MVD: multivessel disease; CTO: chronic total occlusion; CrCL: creatinine clearance; LAD: left anterior descending coronary artery; MI: myocardial infarction; TIMI: thrombolysis in myocardial infarction; PCI: percutaneous coronary intervention.